Clinical Trial Update: Chidamide Bridging for CAR-T Therapy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on chidamide bridging for CAR-T therapy in Non-Hodgkin's Lymphoma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Non Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN